Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15


Deregulation of cancer-stem-cell-associated miRNAs in tissues and sera of colorectal cancer patients.

Farace C, Pisano A, Griñan-Lison C, Solinas G, Jiménez G, Serra M, Carrillo E, Scognamillo F, Attene F, Montella A, Marchal JA, Madeddu R.

Oncotarget. 2020 Jan 14;11(2):116-130. doi: 10.18632/oncotarget.27411. eCollection 2020 Jan 14.


miRNAs as radio-response biomarkers for breast cancer stem cells.

Griñán-Lisón C, Olivares-Urbano MA, Jiménez G, López-Ruiz E, Del Val C, Morata-Tarifa C, Entrena JM, González-Ramírez AR, Boulaiz H, Zurita Herrera M, Núñez MI, Marchal JA.

Mol Oncol. 2020 Mar;14(3):556-570. doi: 10.1002/1878-0261.12635. Epub 2020 Feb 6.


Radiation and Stemness Phenotype May Influence Individual Breast Cancer Outcomes: The Crucial Role of MMPs and Microenvironment.

Olivares-Urbano MA, Griñán-Lisón C, Ríos-Arrabal S, Artacho-Cordón F, Torralbo AI, López-Ruiz E, Marchal JA, Núñez MI.

Cancers (Basel). 2019 Nov 12;11(11). pii: E1781. doi: 10.3390/cancers11111781.


GENYOi005-A: An induced pluripotent stem cells (iPSCs) line generated from a patient with Familial Platelet Disorder with associated Myeloid Malignancy (FPDMM) carrying a p.Thr196Ala variant.

Lamolda M, Montes R, Simón I, Perales S, Martínez-Navajas G, Lopez-Onieva L, Ríos-Pelegrina R, Del Moral RG, Griñan-Lison C, Marchal JA, Lozano ML, Ramos-Mejia V, Rivera J, Bastida JM, Real PJ.

Stem Cell Res. 2019 Dec;41:101603. doi: 10.1016/j.scr.2019.101603. Epub 2019 Oct 15.


Matrix metalloproteases and TIMPs as prognostic biomarkers in breast cancer patients treated with radiotherapy: A pilot study.

Olivares-Urbano MA, Griñán-Lisón C, Zurita M, Del Moral R, Ríos-Arrabal S, Artacho-Cordón F, Arrebola JP, González AR, León J, Antonio Marchal J, Núñez MI.

J Cell Mol Med. 2020 Jan;24(1):139-148. doi: 10.1111/jcmm.14671. Epub 2019 Sep 30.


Pancreatic (pro)enzymes treatment suppresses BXPC-3 pancreatic Cancer Stem Cell subpopulation and impairs tumour engrafting.

Hernández-Camarero P, López-Ruiz E, Griñán-Lisón C, García MÁ, Chocarro-Wrona C, Marchal JA, Kenyon J, Perán M.

Sci Rep. 2019 Aug 6;9(1):11359. doi: 10.1038/s41598-019-47837-7.


LdrB Toxin with In Vitro and In Vivo Antitumor Activity as a Potential Tool for Cancer Gene Therapy.

Jiménez-Martínez Y, Griñán-Lisón C, Khaldy H, Martín A, Cambrils A, Ibáñez Grau A, Jiménez G, Marchal JA, Boulaiz H.

Cancers (Basel). 2019 Jul 20;11(7). pii: E1016. doi: 10.3390/cancers11071016.


Deciphering the Mechanism of Action Involved in Enhanced Suicide Gene Colon Cancer Cell Killer Effect Mediated by Gef and Apoptin.

Cáceres B, Ramirez A, Carrillo E, Jimenez G, Griñán-Lisón C, López-Ruiz E, Jiménez-Martínez Y, Marchal JA, Boulaiz H.

Cancers (Basel). 2019 Feb 23;11(2). pii: E264. doi: 10.3390/cancers11020264.


Enhancement of Tumor Cell Death by Combining gef Gene Mediated Therapy and New 1,4-Benzoxazepin-2,6-Dichloropurine Derivatives in Breast Cancer Cells.

Ramírez A, Conejo-García A, Griñán-Lisón C, López-Cara LC, Jiménez G, Campos JM, Marchal JA, Boulaiz H.

Front Pharmacol. 2018 Jul 26;9:798. doi: 10.3389/fphar.2018.00798. eCollection 2018.


Mesenchymal stem cell's secretome promotes selective enrichment of cancer stem-like cells with specific cytogenetic profile.

Jiménez G, Hackenberg M, Catalina P, Boulaiz H, Griñán-Lisón C, García MÁ, Perán M, López-Ruiz E, Ramírez A, Morata-Tarifa C, Carrasco E, Aguilera M, Marchal JA.

Cancer Lett. 2018 Aug 10;429:78-88. doi: 10.1016/j.canlet.2018.04.042. Epub 2018 May 5.


What's new in the diagnosis of pancreatic cancer: a patent review (2011-present).

Boulaiz H, Ramos MC, Griñán-Lisón C, García-Rubiño ME, Vicente F, Marchal JA.

Expert Opin Ther Pat. 2017 Dec;27(12):1319-1328. doi: 10.1080/13543776.2017.1379991. Epub 2017 Sep 21. Review.


What's new in treatment of pancreatic cancer: a patent review (2010-2017).

Ramos MC, Boulaiz H, Griñan-Lison C, Marchal JA, Vicente F.

Expert Opin Ther Pat. 2017 Nov;27(11):1251-1266. doi: 10.1080/13543776.2017.1349106. Epub 2017 Jul 12. Review.


Cancer suicide gene therapy: a patent review.

Navarro SA, Carrillo E, Griñán-Lisón C, Martín A, Perán M, Marchal JA, Boulaiz H.

Expert Opin Ther Pat. 2016 Sep;26(9):1095-104. doi: 10.1080/13543776.2016.1211640. Epub 2016 Jul 20. Review.


Low adherent cancer cell subpopulations are enriched in tumorigenic and metastatic epithelial-to-mesenchymal transition-induced cancer stem-like cells.

Morata-Tarifa C, Jiménez G, García MA, Entrena JM, Griñán-Lisón C, Aguilera M, Picon-Ruiz M, Marchal JA.

Sci Rep. 2016 Jan 11;6:18772. doi: 10.1038/srep18772.


5-Fluorouracil derivatives: a patent review (2012 - 2014).

Carrillo E, Navarro SA, Ramírez A, García MÁ, Griñán-Lisón C, Perán M, Marchal JA.

Expert Opin Ther Pat. 2015;25(10):1131-44. doi: 10.1517/13543776.2015.1056736. Epub 2015 Jul 13. Review.


Supplemental Content

Loading ...
Support Center